Pfizer's (PFE) Cibinqo Approved in EU for Treatment of Adults with Moderate-to-Severe Atopic Dermatitis
Go back to Pfizer's (PFE) Cibinqo Approved in EU for Treatment of Adults with Moderate-to-Severe Atopic Dermatitis| Pfizer Inc. (NYSE: PFE) | Delayed: 28.15 -0.15 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.30 | 52 Week High | $37.39 | |||
| Open | $27.97 | 52 Week Low | $28.25 | |||
| Day High | $28.17 | P/E | 17.06 | |||
| Day Low | $27.83 | EPS | $1.65 | |||
| Volume | 11,956,000 | |||||
